Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Average Recommendation of “Moderate Buy” from Brokerages

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has been assigned a consensus rating of “Moderate Buy” from the ten analysts that are covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $22.30.

SBRA has been the topic of a number of analyst reports. Wells Fargo & Company boosted their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an “overweight” rating in a research note on Thursday, March 26th. UBS Group boosted their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday, May 13th. Citigroup upped their target price on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, February 18th. Truist Financial upped their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research note on Friday, March 13th. Finally, Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Monday, May 18th.

Hedge Funds Weigh In On Sabra Healthcare REIT

Institutional investors have recently added to or reduced their stakes in the business. Cornerstone Wealth Management LLC increased its stake in Sabra Healthcare REIT by 256.6% in the 3rd quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust’s stock worth $742,000 after acquiring an additional 28,625 shares during the last quarter. AlphaQuest LLC increased its stake in Sabra Healthcare REIT by 309.2% in the 3rd quarter. AlphaQuest LLC now owns 144,839 shares of the real estate investment trust’s stock worth $2,700,000 after acquiring an additional 109,444 shares during the last quarter. Bank of Montreal Can increased its stake in Sabra Healthcare REIT by 8.2% in the 3rd quarter. Bank of Montreal Can now owns 2,787,655 shares of the real estate investment trust’s stock worth $51,962,000 after acquiring an additional 211,686 shares during the last quarter. Allianz Asset Management GmbH increased its stake in Sabra Healthcare REIT by 9.9% in the 3rd quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust’s stock worth $16,832,000 after acquiring an additional 81,293 shares during the last quarter. Finally, Principal Financial Group Inc. increased its stake in Sabra Healthcare REIT by 21.6% in the 4th quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after acquiring an additional 4,431,897 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Stock Performance

NASDAQ:SBRA opened at $19.89 on Friday. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. Sabra Healthcare REIT has a 52-week low of $17.13 and a 52-week high of $21.28. The firm has a market cap of $5.02 billion, a price-to-earnings ratio of 31.57, a PEG ratio of 1.52 and a beta of 0.67. The business’s fifty day moving average is $20.29 and its 200 day moving average is $19.70.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The company had revenue of $211.74 million for the quarter, compared to analyst estimates of $209.20 million. During the same period in the previous year, the company posted $0.37 EPS. The firm’s revenue for the quarter was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts predict that Sabra Healthcare REIT will post 1.51 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.0%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio is currently 190.48%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.